Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001839 |
---|---|
Receipt number | R000002215 |
Scientific Title | Phase II clinical trial of personalized peptide vaccination for primary lung cancer |
Date of disclosure of the study information | 2009/04/05 |
Last modified on | 2019/10/30 12:55:33 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/04/01 21:06:18 | ||
2 | Update | 2009/04/03 20:40:18 | Public title Acronym |
|
3 | Update | 2009/04/03 20:51:16 | Narrative objectives1 Narrative objectives1 Basic objectives2 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
4 | Update | 2009/04/03 20:58:46 | Last name of lead principal investigator Division name Address Address Last name of contact person Division name Division name Address Address Address Address Institute Institute Organization Organization Category of Funding Organization Organization1 Address1 Tel1 Email1 |
|
5 | Update | 2009/04/03 20:59:59 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
6 | Update | 2009/04/03 21:08:34 | Basic design Blinding No. of arms Type of intervention Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria Key exclusion criteria |
|
7 | Update | 2009/04/04 10:14:44 | Classification by specialty |
|
8 | Update | 2009/04/04 10:15:35 | Last name of lead principal investigator |
|
9 | Update | 2009/04/10 16:33:29 | Recruitment status |
|
10 | Update | 2011/09/26 11:30:50 | UMIN ID1 |
|
11 | Update | 2011/09/28 10:28:03 | Recruitment status |
|
12 | Update | 2011/11/04 12:14:54 | Last name of contact person Name of person sending information Name of person sending information Organization Division name Division name Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
13 | Update | 2011/11/16 14:16:56 | Public title Public title Acronym Acronym |
|
14 | Update | 2011/11/16 14:21:14 | Condition Condition Narrative objectives1 Narrative objectives1 |
|
15 | Update | 2011/11/16 14:35:51 | Key inclusion criteria Key inclusion criteria |
|
16 | Update | 2011/11/16 14:42:40 | Key inclusion criteria |
|
17 | Update | 2012/10/22 17:42:18 | Co-sponsor Co-sponsor |
|
18 | Update | 2013/05/10 11:30:23 | Recruitment status |
|
19 | Update | 2014/07/07 15:10:34 | Last name of lead principal investigator Last name of lead principal investigator Organization Division name Division name Address Address TEL Institute Institute Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
20 | Update | 2014/07/07 15:15:26 | Recruitment status |
|
21 | Update | 2014/12/08 16:09:48 | Key secondary outcomes |
|
22 | Update | 2014/12/08 16:12:42 | Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
23 | Update | 2019/01/07 10:41:15 | Recruitment status |
|
24 | Update | 2019/10/30 12:55:33 | Recruitment status Date of IRB |